Clinical Trials Directory

Trials / Completed

CompletedNCT06262347

Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD

NIDA CTN Protocol 0150: Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD: A Pilot Randomized Trial (TOME Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
131 (actual)
Sponsor
T. John Winhusen, PhD · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to evaluate the ability of TOME to increase Medication for Opioid Use Disorder (MOUD) and opioid-overdose knowledge in pregnant and postpartum persons.

Detailed description

This is an intent-to-treat, two-arm, open-label, randomized controlled trial. Eligible participants will be randomized in a 1:1 ratio to TOME or Control, balancing on site. Participants will receive the assigned intervention following randomization and will complete a three week follow-up assessment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPersonally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME)The TOME intervention is a modified version of the personally-tailored opioid overdose prevention education and naloxone distribution (PTOEND) intervention (Winhusen et al. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Drug Alcohol Depend. Nov 1 2020;216:108265). Modifications include updating the knowledge assessment/education to reflect changes in the drug supply (i.e., the current high prevalence of fentanyl and increasing prevalence of xylazine) and the addition of items specific to pregnancy. Like PTOEND, TOME is a computer-guided intervention which utilizes REDCap to complete assessments and automatically generate personally-tailored feedback reports.
BEHAVIORALControlParticipants randomized to the control condition will be offered three SAMHSA handouts.

Timeline

Start date
2024-06-13
Primary completion
2024-11-11
Completion
2024-11-11
First posted
2024-02-16
Last updated
2025-05-11
Results posted
2025-05-11

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06262347. Inclusion in this directory is not an endorsement.